Clinical Trials Logo

Clinical Trial Summary

Epilepsy with centrotemporal spikes (ECTS) is the most common epilepsy syndrome in children. Language impairment has been widely investigated in patients with ECTS, but little is known about the cognitive dysfunction of processing speed and its neuroimaging mechanism.


Clinical Trial Description

OBJECTIVE To investigate the processing speed dysfunction in patients with ECTS, and the associated brain functional abnormality using functional magnetic resonance imaging (fMRI) and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET). DESIGN, SETTING, AND PARTICIPANTS This study prospectively enrolled ECTS patients (n = 28) from June 2019 and June 2021. Twenty age- and gender- matched healthy children and another twenty children with extracranial tumors were enrolled as controls. Patients with ECTS and healthy controls underwent neuropsychological testing and fMRI examination. In addition, ECTS patients and children with extracranial tumors underwent 18F-FDG PET examination. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04954729
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Completed
Phase
Start date June 1, 2019
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03465566 - Emotion Recognition in Benign Epilepsy of Childhood With Centro-Temporal Spikes (BECTS)
Terminated NCT00471744 - HEAD-Study Optimizing the Treatment of Children With BECTS Phase 3
Completed NCT00216567 - Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy Phase 4